Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05719077
Other study ID # Pro2021001817
Secondary ID R00AG065624
Status Recruiting
Phase N/A
First received
Last updated
Start date October 6, 2023
Est. completion date February 28, 2026

Study information

Verified date May 2024
Source Rutgers, The State University of New Jersey
Contact Elizabeth Luth, PhD
Phone 646-512-0670
Email eal133@ifh.rutgers.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of a clinically useful, inclusive dementia-enhanced training and tool for use by home hospice clinicians to improve care and support for Black and White patients with dementia and their family caregivers. The investigators expect family caregivers of clinicians in the intervention group will report less caregiver burden (primary outcome) than caregivers of clinicians in the control group. The investigators expect that, compared to clinicians in the control group (usual care), clinicians in the intervention group (receive the training and use the tool) will demonstrate more knowledge of dementia-related caregiving issues (secondary outcomes). In exploratory analyses, the investigators expect family caregivers will report greater self-efficacy and preparedness, and that patients of clinicians in the intervention group will experience fewer live discharges than family caregivers of patients of clinicians in the control group.


Description:

For this aim, the investigators will conduct a randomized pilot study to determine the feasibility and acceptability of implementing the training and tool in clinical practice compared to usual care with 40 clinicians (20 intervention, 20 control) and 160 Black and white FCG (80 intervention, 80 control). The investigators will also determine preliminary efficacy of the training and tool. Outcomes include feasibility and acceptability of the intervention, reducing FCG burden (primary outcome), improving clinician knowledge and confidence (secondary outcomes) and increasing FCG preparedness and self-efficacy.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date February 28, 2026
Est. primary completion date September 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 90 Years
Eligibility Inclusion Criteria: - Individuals are not excluded from this study based on gender. - Based on proportion of hospice workforce and family caregivers that are female, we expect 70%-80% of participants will be female. - Nurse, social worker, or family member who provides care to persons(s) living with dementia enrolled in home hospice care. - 19-90 years old. - Can complete data collection in English. - Family Caregivers: identify as White or Black/African American. Exclusion Criteria: - Participant is less than 19 years old or older than 90 years old. - Does not provide care to person(s) living with dementia enrolled in home hospice. - Cannot complete data collection in English. - Family Caregiver does not identify as White or Black/African American.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
EDITH-HC
This study tests feasibility and acceptability of implementing a tool and training in a clinical practice and the preliminary efficacy of training materials to enhance hospice clinicians' knowledge of dementia-related caregiving issues at end of life and a tool for clinicians to use to address caregiving issues related to dementia at end of life.

Locations

Country Name City State
United States Rutgers Univeristy New Brunswick New Jersey

Sponsors (2)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Family caregiver self-efficacy (exploratory) The investigators will assess caregiver self-efficacy using the validated, 8-item Caregiver Self-Efficacy Scale (CSES). The investigators will assess changes in caregiver self-efficacy between baseline and subsequent hospice visits and compare differences in changes between the intervention and control groups. The same issues due to attrition described in 1. Family Caregiver burden above also apply here. Baseline and through intervetion completion, an average of 8 weeks
Other Family caregiver preparedness (exploratory) The investigators will assess caregiver preparedness for dementia caregiving using a single-item question about the extent to which caregivers feel prepared to provide care to their loved one and the 9-item Preparedness Scale of the Family Care Inventory. The investigators will assess changes at baseline and subsequent hospice visits and compare differences in changes between the intervention and control groups. The same issues due to attrition described in 1. Family Caregiver burden above also apply here. Baseline and through intervention completion, an average of 8 weeks
Other Patient hospice discharge status (exploratory) The investigators will assess patient status upon hospice discharge as either deceased or alive. The investigators will assess patient discharge status as reported in the electronic hospice records. The investigators will compare discharge status of hospice patients with study-enrolled caregivers between intervention and control groups. 3 months post-intervention, 6 months post-intervention
Primary Family Caregiver Burden The investigators will assess this outcome using the validated, 12-item Zarit Caregiver Burden Inventory. The investigators will assess changes in reported caregiver burden between baseline and subsequent hospice visits and compare differences in changes between the intervention and control groups. Because family caregiver participants are relatives of hospice patients that may die (at which point they will no longer be receiving home visits from nurses and social workers), the investigators expect that many participants will not complete all four time points of data collection. Baseline and through intervention completion, an average of 8 weeks
Secondary Clinician knowledge of dementia-related issues at end of life The investigators will assess clinician knowledge of dementia-related issues at end of life using a revised Dementia Knowledge Assessment Scale and assessment questions that are tailored to the content of the training. The investigators will assess changes in reported knowledge between baseline and after completing the training. The investigators will compare differences in changes between clinicians receiving the training (intervention) and those receiving a presentation on patterns of hospice outcomes for persons living with dementia (control). Baseline and through training completion, an average of 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT04457973 - Home-based Transcranial Direct Current Stimulation for Pain Management in Persons With Alzheimer's Disease and Related Dementias N/A
Completed NCT04857060 - Palliative Care Educator N/A
Completed NCT04179721 - Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2) N/A
Recruiting NCT06335953 - ALIGN: Aligning Medications With What Matters Most (Demonstration) N/A
Completed NCT05255068 - OPTIMAL in NH Residents With Dementia N/A
Recruiting NCT06276023 - Supporting Our Caregivers In ADRD Learning (SOCIAL) N/A
Recruiting NCT05877391 - Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
Completed NCT01498263 - Inherited Diseases, Caregiving, and Social Networks
Completed NCT04481568 - Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1) N/A
Recruiting NCT03848312 - Preventing Alzheimer's With Cognitive Training Phase 3
Recruiting NCT05825404 - Smart Lighting for Nursing Home Residents With Dementia N/A
Recruiting NCT06421545 - Resilient Together for Dementia N/A
Not yet recruiting NCT05942040 - Translating Data Science to Palliative Care N/A